Status:
COMPLETED
Diaphragmatic Paralysis Comparison Between Local Anesthetic Volumen Doses After Interscalene Block
Lead Sponsor:
Instituto de Investigación Sanitaria Aragón
Collaborating Sponsors:
Hospital Miguel Servet
Conditions:
Diaphragmatic Paralysis
Brachial Plexus Block
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Arthroscopic shoulder surgery involves dynamic and severe postoperative pain. Interscalene brachial plexus block (IBPB) provides adequate analgesia but the spread of local anaesthetics administered ca...
Detailed Description
Arthroscopic shoulder surgery involves dynamic and severe postoperative pain. Interscalene brachial plexus block (IBPB) provides adequate analgesia but the spread of local anaesthetics administered ca...
Eligibility Criteria
Inclusion
- Patients aged 18 to 80 years.
- ASA I-III.
- Scheduled for shoulder arthroscopic shoulder surgery and interscalene brachial plexus block.
Exclusion
- Age \<18 and \>80 years.
- Pregnancy.
- Exclusión to perform IBPB or spirometry.
- Allergy to amide group local anaesthetics, opioids or nonsteroidal anti-inflammatory drugs.
- Background of Pulmonary diseases (chronic obstructive pulmonary disease (COPD) and moderate, severe or not well-controlled asthma), diaphragmatic paralysis or neurological disease with diaphragmatic dysfunction, brachial plexus neuropathy or chronic opioid consumption (more than 3-months consumption or more than oral Morphine 1 mg 1-month).
- Coagulation disorders (INR\>3, TTPA \> 35 y AP \<50%).
Key Trial Info
Start Date :
February 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04385966
Start Date
February 11 2020
End Date
October 20 2021
Last Update
August 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Miguel Servet
Zaragoza, Spain, 50012